LEGN Legend Biotech Corporation
Healthcare$29.37+4.93%ClosedMarket Cap: $5.43B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$58.00
Target (Median)
$64.00
Target Range
$24.00 - $75.00
Upside from current price: 97.5%
Rating Distribution
5 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-13 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-13 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-13 | TD Cowen | maintain | Hold | Hold |
| 2026-04-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-11 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-11 | RBC Capital | maintain | Outperform | Outperform |
| 2026-02-04 | Barclays | maintain | Overweight | Overweight |
| 2026-01-22 | TD Cowen | downgrade | Hold | Buy |
| 2026-01-22 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.90 | $1.81B | 4 |
| Sun Dec 31 | $1.58 | $2.10B | 1 |
| Mon Dec 31 | $1.53 | $2.41B | 1 |
| Tue Dec 31 | $2.01 | $2.70B | 1 |